Leo Ehrlich gave $4 million dollars of shareholders’ money - more than half of IPIX’ cash at that time, and infinitely more now - to an offshore entity in a completely unrelated field rather than conduct research in the field you highlight, or indeed in any potential indication for brilacidin.
In the meantime Leo and Redbrick Jane continue to pay themselves roughly $1 million each and every year, including this year even as Cumming’s bailiffs are about to hammer in their door.
What does that tell you about brilacidin’s prospects as a therapeutic, and about the integrity of what passes for IPIX’ management?
Bearish
News 
Market Data 
Discover 
AI
